Heartflow Inc.
Organization details
- Legal name
- Heartflow Inc.
- Former names
- Cardiovascular Simulation, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HTFL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001464521
- EIN
- 26-0506743
Board of directors
-
Casey M. Tansey · DirectorSince 2025
-
Jeffrey C. Lightcap · DirectorSince 2025
-
John C.m. Farquhar · Director · Chief Executive OfficerSince 2025
-
Julie A. Cullivan · DirectorSince 2025
-
Nicholas Downing · DirectorSince 2025
-
Timothy C. Barabe · DirectorSince 2025
-
Wayne Joseph Riley · DirectorSince 2025
-
William C. Weldon · DirectorSince 2025
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
39.9% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.6%
-
90.1%
Board connections
5 of this board's directors also sit on 8 other boards. 7 are in the same sector.
- via Julie A. Cullivan
-
COMPASS Pathways Plc Same sectorvia Wayne Joseph Riley
-
Cartesian Therapeutics Inc. Same sectorvia Timothy C. Barabe
-
HCA Healthcare Inc. Same sectorvia Wayne Joseph Riley
-
Inspire Medical Systems Inc. Same sectorvia Casey M. Tansey
-
Mobia Medical Inc. Same sectorvia Casey M. Tansey
-
NewAmsterdam Pharma Company N.V. Same sectorvia Nicholas Downing
-
Shoulder Innovations Inc. Same sectorvia Casey M. Tansey
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,053,600
- 1 purchase by 1 insider
- Sold, last 12 months
- $141,751,923
- 39 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Option exercise | +15,620 | $2.22 | $34,676 |
| Nov 10, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Open-market sale | −38,900 | $55.74 | $2,168,286 |
| Nov 9, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −3,587 | $53.15 | $190,649 |
| Nov 6, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Shares withheld for tax | −7,751 | $52.40 | $406,152 |
| Nov 6, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Shares withheld for tax | −2,270 | $52.40 | $118,948 |
| Nov 6, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Shares withheld for tax | −2,009 | $52.40 | $105,272 |
| Nov 6, 2026 | Jones Marie L. Officer (Chief Accounting Officer) | Shares withheld for tax | −568 | $52.40 | $29,763 |
| Oct 22, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Option exercise | +12,329 | $8.33 | $102,701 |
| Oct 22, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Option exercise | +5,101 | $2.22 | $11,324 |
| Oct 22, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Open-market sale | −23,933 | $55.01 | $1,316,554 |
| Sep 18, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Option exercise | +12,329 | $8.33 | $102,701 |
| Sep 18, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −16,766 | $50.75 | $850,875 |
| Sep 18, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Option exercise | +850 | $2.22 | $1,887 |
| Sep 18, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Open-market sale | −19,682 | $50.15 | $987,052 |
| Sep 17, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −7,579 | $50.11 | $379,784 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Heartflow Inc.
Who is the CEO of Heartflow Inc.?
John C.m. Farquhar has been Heartflow Inc.'s Chief Executive Officer since August 2025.
How many directors are on Heartflow Inc.'s board?
Heartflow Inc.'s board has 8 directors: Casey M. Tansey, Jeffrey C. Lightcap, John C.m. Farquhar, Julie A. Cullivan, Nicholas Downing, Timothy C. Barabe, Wayne Joseph Riley and William C. Weldon.
Are Heartflow Inc. insiders buying or selling shares?
Over the last 12 months, Heartflow Inc. insiders bought $1.1 million of shares in 1 purchase and sold $141.8 million of shares in 39 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="heartflow-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.